Skip to content
LongevityGraded

Review

MyDrHank Reviews: "From $137" With No Term Attached

MyDrHank NAD+ starts at $137 a month for the nasal spray and $155 for the weekly injection, with no plan length shown. Free consult, no bloodwork to start.

Researched & graded by · Lead Reviews Analyst
Last graded
On this page

The one-sentence version

MyDrHank sells NAD+ two ways most providers here do not — a daily nasal spray or a weekly subcutaneous injection — with the clinician review stated as free, no bloodwork required to start, and ongoing messaging with a care team inside the service. Then it does the one thing this site penalizes hardest: every price it shows is a "From" figure — $137 a month for the nasal spray and sermorelin, $155 for the injection — with no plan length beside it and no month-to-month price anywhere on its product pages. You cannot tell what one month costs until you are inside the intake. It grades B, 10 points out of 14, and it loses all four of them in the same place. MyDrHank is a partner here.

What it is, and who it's for

The operator is Dr. Hank, LLC, trading as MyDrHank, and the site carries a LegitScript certification seal. It is a general telehealth platform, not a longevity clinic, and its own navigation says so: six lines sold from one account — Weight Loss, Longevity, Peptides & NAD+, Sexual Health, Hair Growth and Strength.

That matters for expectation-setting more than for grading. The longevity line itself is real and deeper than several specialists here: NAD+ Nasal Spray, NAD+ Injection, Glutathione Nasal Spray, Glutathione Injection and Sermorelin. If the glutathione injection is what you are after, read what the FDA's August alert on glutathione injectables means first; it concerns IV glutathione that several compounding pharmacies made from one supplier's dietary-supplement-grade lot, and it names no telehealth seller. Five of the fifteen products on the catalog are the NAD+ and peptide routes this site is built to rank, which is the whole of the four points it takes on the longevity-line factor. But NAD+ sits on the same account as erectile-dysfunction tablets, finasteride and compounded tirzepatide, and if you want a practice whose entire business is the thing you are buying, System Labs and Telos Rx are the shape you are looking for.

Onboarding is deliberately frictionless: "A 3-minute medical questionnaire — no office visits, no insurance, no bloodwork required to start," then "A U.S. board-certified clinician reviews your intake within 24 hours and builds a protocol tailored to your goals." If you wanted baseline biomarkers before starting, nothing here measures anything — see longevity biomarker panels.

What it actually costs, and what "$137" is doing

All figures below are from MyDrHank's own pages.

What the site shows you. The product pages print "From $137 /mo" for the NAD+ nasal spray, "From $155 /mo" for the NAD+ injection and "From $137 /mo" for sermorelin, beside "No insurance required · Free consultation · Transparent pricing · Free delivery."2 The NAD+ lander leads with the same $137 and adds "Cancel anytime. Prescription only following evaluation by a U.S.-licensed clinician. Available in select states."

What the site does not show you. No plan selector, no plan length and no monthly figure appears beside any of those prices. "From" tells you $137 is the lowest rate on offer; it does not tell you whether that is a single month, a quarter or a year paid up front. Many providers here reach a low "from" figure only on a long prepay, so ask before you assume $137 is what one month costs.

What the price pages show

NAD+ nasal sprayFrom $137/moNoNo
NAD+ injectionFrom $155/moNoNo
SermorelinFrom $137/moNoNo
From MyDrHank's product pages. Each shows one "From" figure and no plan length.

Why that decides the price factor. Our rubric asks for a single all-in figure, visible before you commit, that a buyer with no commitment actually pays. A floor with no term attached is not that figure, so price transparency scores zero. Compare Enhance MD, which advertises a $169 twelve-month rate and keeps its four points because the $199 month-to-month price sits on the same page, and System Labs, which prints its standing rate beside its first-month teaser.

One more qualifier on top. "Final pricing depends on the protocol and dose prescribed" sits directly beneath the headline, so even the $137 is a floor rather than a quotation.

The dose promise does not transfer. MyDrHank's weight-loss funnel makes a clean, checkable commitment in its own FAQ: "Plans start at $171/mo with no contract. This covers your physician review, personalized treatment plan, prescription medication, and free shipping directly to your door. The price stays the same at every dose — no surprise price increases." No equivalent promise appears anywhere on the NAD+ or sermorelin line. The longevity pages say the opposite — that final pricing depends on the dose prescribed. If you found MyDrHank through its GLP-1 marketing and assumed the dose-flat pricing carried across, it does not, and you should ask before you titrate. For what this category costs generally, see longevity clinic cost.

Clinical oversight and the pharmacy

Oversight: two points, earned. The NAD+ lander states "Free consultation" on its face and a banner across the top reads "Limited time — Free physician consultation with your first order." That is MyDrHank's own statement that the clinician review sits inside the price rather than being billed on top, which is the same standard that credited Strut Health for its free online MD visit. Note the framing honestly: it is described as a limited-time promotion tied to a first order, not a standing term, so confirm it is still on offer when you start.

Support: two points, earned. MyDrHank's own longevity page publishes "Ongoing clinical support — Check-ins, dose adjustments, and unlimited messaging with your care team" as part of the service. Stated support inside the price is what this factor asks for, and most providers here do not state it at all.

Pharmacy: two points, and they come with an asterisk. MyDrHank publishes a compounding standard on a surface it controls — its weight-loss lander footnotes read "Compounded semaglutide and tirzepatide are prepared by FDA-registered outsourcing or 503A pharmacies" — and our rule turns on where a claim is published, not on how prominently. So it scores the top rung. What you should know is that the claim is scoped to the weight-loss line. The disclosure attached to the products this review is actually about reads: "NAD+ dispensed through MyDrHank is a compounded medication prepared by a state-licensed U.S. compounding pharmacy. Compounded drugs are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality." That is a license, not a section, and no dispensing facility is named on either line.

We could have written a sub-rule requiring the 503A claim to cover the graded product and scored MyDrHank zero. We did not, for the reason recorded against Shed when the same temptation came up there: inventing a rule after seeing which provider it demotes is exactly the tuning a published rubric exists to prevent. The scoping is disclosed to you here instead, which is where it is useful. FDA's own position on what an unnamed compounder leaves open is blunt: compounded drugs are not FDA-approved, and the agency does not verify their safety, effectiveness or quality before they are marketed1.

Where it will treat you. The consumer pages say only "Available in select states" and publish no list, so confirm your state with the company before you start rather than after paying.

What the research says, in short

MyDrHank markets NAD+ as "Steady, all-day cellular energy," "Sharper focus & mental clarity," "Better sleep & faster recovery" and "Supports healthy aging at the cellular level." Those are the category's standard claims, and the research does not yet back them.

Human evidence that NAD+ slows aging or lifts energy and focus is still thin, and there is less still for the injected and nasal routes MyDrHank sells.

None of that is a mark against MyDrHank specifically — it is the state of the category, and this site grades providers rather than the medicine. But if $137 turns out to need a long plan, a buyer is committing well over a thousand dollars to a treatment whose advertised outcomes have not been shown in people. Read NAD+ for longevity, do NAD+ peptides actually work and what's proven versus hyped before you decide the term is worth it.

Before you start

Five things to settle before you pay MyDrHank

  • Get the one-month price and the plan length in writing. The pages show only "From $137" (nasal spray, sermorelin) and "From $155" (injection), with no term.
  • Ask what your prescribed dose costs. The NAD+ line says final pricing depends on the dose — and unlike the weight-loss line, it makes no promise the price holds across doses.
  • Confirm the free consultation still applies. It is advertised as a limited-time offer attached to a first order, not a standing term.
  • Ask which pharmacy dispenses, and under which section. The 503A claim covers the weight-loss line; the NAD+ disclosure says only "a state-licensed U.S. compounding pharmacy", and neither names a facility.
  • Check your state first. The site says only "available in select states" and publishes no list.

Where it's weak, and who should skip it

Skip it if you intend to buy a month and stop, because that is precisely the purchase MyDrHank does not price: get the one-month figure in writing before you treat $137 as your number. Skip it if you need to know what the dose you end up on will cost, because the longevity line explicitly reserves that — and unlike the weight-loss line, it makes no promise that the price holds across doses. Skip it if you want to know which pharmacy fills your vial, since none is named on any line. And check the six excluded states before you start.

Buy it if the delivery routes are what you actually want. A daily nasal spray or a weekly injection, chosen by the prescriber rather than by whatever the shop happens to stock, with the visit free, no bloodwork gate, and unlimited messaging with a care team, is a genuinely reasonable starting position — provided you get the plan length behind the price before you pay.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). MyDrHank takes the full four for its longevity line — NAD+ by two routes, glutathione by two more, plus sermorelin — two for clinical oversight, because the consultation is stated as free, two for human support, because ongoing check-ins and unlimited messaging are published as part of the service, and two for pharmacy, because a 503A claim appears on a surface it controls. It takes zero for price transparency, because no month-to-month figure is published anywhere and the number it does publish carries no term. Ten out of fourteen: a B.

The fix is simple: publish the monthly price. Printing the one-month figure beside $137 and labeling which is which would move MyDrHank to fourteen without changing a single term of the offer. Until it does, the headline is the cheapest thing about it. The full graded field is at our provider rankings, the scoring is set out in how we grade, and two neighbors with a similar headline read differently: our Enhance MD review, which publishes the month-to-month price beside the prepay one, and our System Labs review, which publishes the standing rate beside the teaser.

Compare MyDrHank with

We may earn a commission through these links, at no extra cost to you. Disclosure

B

Featured partner

CoreAge Rx $93–$99/mo (starting rates)

Visit CoreAge Rx

See every graded provider ↗

Frequently asked questions

How much does MyDrHank NAD+ cost?

MyDrHank's product pages show NAD+ nasal spray 'From $137 /mo', NAD+ injection 'From $155 /mo' and sermorelin 'From $137 /mo'. None of them shows a plan length or a month-to-month price, so you cannot tell from the site whether $137 is what one month costs or the rate on a longer prepaid plan. The NAD+ lander adds a further qualifier: 'Final pricing depends on the protocol and dose prescribed.' The consultation is stated as free and delivery is free. Ask for the one-month price and the plan length in writing before you pay.

Is MyDrHank legit?

Yes — MyDrHank is a real telehealth platform operated by Dr. Hank, LLC, LegitScript-certified, and it grades a B at 10 points out of 14 on our rubric. A U.S. board-certified clinician reviews every intake before anything ships, the consultation is stated as free, no bloodwork is required to begin, and 'Ongoing clinical support — check-ins, dose adjustments, and unlimited messaging with your care team' is published as part of the service. Three things belong in the same answer. It is a general telehealth platform rather than a longevity specialist: NAD+ sits alongside weight loss, sexual health, hair growth and strength on one account. Its advertised price is a 'From' figure with no plan length beside it. And no dispensing pharmacy is named — the 503A standard it publishes is stated for its compounded semaglutide and tirzepatide, while the NAD+ disclosure says only 'a state-licensed U.S. compounding pharmacy'.

How is MyDrHank's NAD+ delivered?

Two routes, and the prescriber picks between them: 'Through a daily nasal spray or a weekly subcutaneous injection. Your prescribing clinician will recommend the format that best fits your goals, schedule, and tolerance.' That is a genuinely broader offering than most providers here, which typically sells one route. The wider longevity catalog runs NAD+ Nasal Spray, NAD+ Injection, Glutathione Nasal Spray, Glutathione Injection and Sermorelin, and that depth is why MyDrHank takes the full four points on our longevity-line factor. Before you choose, know that human evidence for NAD+ as an anti-aging treatment is thin for every route, and thinnest for injections and nasal sprays.

Does MyDrHank's price stay the same at every dose?

On the weight-loss line, yes — its GLP-1 FAQ says in writing: 'Plans start at $171/mo with no contract. This covers your physician review, personalized treatment plan, prescription medication, and free shipping directly to your door. The price stays the same at every dose — no surprise price increases.' On the NAD+ and sermorelin line, no such promise appears anywhere, and the longevity lander states the opposite: 'Final pricing depends on the protocol and dose prescribed.' We checked specifically because the two claims are easy to conflate if you arrive through MyDrHank's weight-loss marketing. If you are buying NAD+ or sermorelin, ask what a dose increase costs before you titrate, because the company has not committed to holding the price on that line.

Which states does MyDrHank serve?

MyDrHank does not publish a list. Its consumer-facing pages say only 'Available in select states' and 'NAD+ is available in select U.S. states', with no roster of served or excluded states. Confirm your state directly with the company before paying rather than discovering it after an intake — a prescription is issued only following evaluation by a U.S.-licensed clinician, and eligibility is confirmed at that stage rather than at checkout.

Why does MyDrHank grade B rather than A?

Ten points out of fourteen, and all four it drops are on one factor: price transparency, which our rubric weights double. MyDrHank publishes no month-to-month figure anywhere: every price surface prints a lone 'From $137' or 'From $155' with no plan length beside it, so no figure a buyer could commit against is shown. That is the difference between MyDrHank and Enhance MD, which advertises a twelve-month rate but publishes its $199 month-to-month price on the same page and keeps its four points. Everything else scores: four for a genuine longevity line (NAD+ by two routes, glutathione by two more, plus sermorelin), two for a consultation stated as free, two for ongoing support published as part of the service, and two for a 503A claim on a surface the company controls — though that claim is scoped to its weight-loss line, and no pharmacy is named on either.

References

  1. U.S. Food and Drug Administration (2025). Compounding and the FDA: Questions and Answers ('Compounded drugs are not FDA-approved'; 503A pharmacies are not subject to CGMP requirements). FDA — Human Drug Compounding.
  2. MyDrHank (2026). NAD+ nasal spray, NAD+ injection and sermorelin product pages. MyDrHank website.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.